Inefficiency of the gut microbiota to produce microbiota-derived AHR agonists from tryptophan was closely associated with the pathogenesis of inflammatory bowel disease, notably through impaired IL-22 (21). The gene discussed is AHR; the disease is inflammatory bowel disease.